Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
Improved models of care for cancer survivors
2022 Standout
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
2021 Standout
Works of V. Westeel being referenced
Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC).
2010
Maintenance with either gemcitabine or erlotinib versus observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy in advanced NSCLC: IFCT-GFPC 0502 phase III study.
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| V. Westeel | 191 | 253 | 109 | 20 | 314 | |
| J.R. Fischer | 181 | 232 | 71 | 19 | 284 | |
| Scott Grant | 100 | 179 | 90 | 15 | 342 | |
| Emiko Ohki | 145 | 164 | 67 | 22 | 316 | |
| Francine Fein | 123 | 186 | 72 | 24 | 322 | |
| Abel Botelho Quaresma | 83 | 109 | 86 | 22 | 282 | |
| Harumichi Ikegami | 158 | 221 | 123 | 30 | 356 | |
| Marco Ligi | 83 | 168 | 98 | 23 | 358 | |
| M. Locatelli-Sanchez | 178 | 173 | 32 | 17 | 292 | |
| T.J. Crook | 98 | 96 | 76 | 20 | 314 | |
| Marshall Posner | 121 | 124 | 36 | 12 | 318 |
All Works
Loading papers...